US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

46.53

-0.3867-0.82%

Volume:5.07M

Turnover:236.62M

Market Cap:94.70B

PE:17.43

High:46.91

Open:46.87

Low:46.33

Close:46.92

Loading ...

Overview Company News Filings

ACADIA Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior VP, Rare Disease Franchise

BRIEF-Bristol-Myers Squibb Canada Says New Subcutaneous Formulation Of Opdivo Approved In Canada

Bristol-Myers Squibb Canada: New Subcutaneous Formulation of Opdivo Approved in Canada for Use Across All Authorized Solid Tumour Indications

THOMSON REUTERS

Prothena Corporation plc Publishes Presentation on Advancements in Life-Saving Therapies for Protein Dysregulation Diseases

Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank

Serina Therapeutics Announces Board Changes: Welcomes Dr. Stephen Brannan, Bids Farewell to Remy Gross

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors

Bristol Myers Squibb to Participate in Bernstein 41st Annual Strategic Decisions Conference

He called the S&P 500 bottom. Now this stock trader can't rule out a 'flash crash.'

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Prime Medicine Announces Promising Initial Clinical Data for PM359 in Chronic Granulomatous Disease Trial

This stock trader called a bottom for the S&P 500. Here's what he's saying now.

European Commission Approves Opdivo Regimen for Treatment of High-Risk Non-Small Cell Lung Cancer, Announce ONO Pharmaceutical and Bristol Myers Squibb

Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as New Head of R&D and Chief Medical Officer

Bristol-Myers Squibb Receives European Approval for Opdivo Regimen to Treat Lung Cancer

MT Newswires Live

BRIEF-Bristol Myers Squibb Receives European Commission Approval For Perioperative Regimen Of Neoadjuvant Opdivo(Nivolumab) And Chemotherapy Followed By Adjuvant Opdivo For Resectable, High-Risk Non-Small Cell Lung Cancer With Pd-L1 Expression ≥1%

Bristol-Myers Squibb Secures European Commission Approval for Opdivo Regimen in Treating High-Risk Non-Small Cell Lung Cancer

Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (Nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer With Pd-L1 Expression ≥1%

THOMSON REUTERS

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer

Bristol Myers Squibb Co. Stock Slides 5.3%, Underperforms Competitors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BMY/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"Bristol-Myers Squibb","latestPrice":46.5333,"timestamp":1751907004130,"preClose":46.92,"halted":0,"volume":5073967,"delay":0,"floatShares":2031243258,"shares":2035080810,"eps":2.670473,"marketStatus":"Trading","change":-0.3867,"latestTime":"07-07 12:50:05 EDT","open":46.87,"high":46.91,"low":46.33,"amount":236623182.55324998,"amplitude":0.012361,"askPrice":46.54,"askSize":202,"bidPrice":46.53,"bidSize":39,"shortable":3,"etf":0,"ttmEps":2.670473,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1751918400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":46.92,"dividendRate":0.052436,"preHourTrading":{"tag":"盘前","latestPrice":46.85,"preClose":46.92,"latestTime":"09:20 EDT","volume":10384,"amount":487399.747648,"timestamp":1751894438724},"postHourTrading":{"tag":"盘后","latestPrice":47.05,"preClose":46.92,"latestTime":"16:57 EDT","volume":255666,"amount":11996805.9818,"timestamp":1751576279127},"volumeRatio":0.616759,"impliedVol":0.3564,"impliedVolPercentile":0.768},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2031243258,"roa":"7.24%","roe":"31.99%","lyrEps":-4.414405,"volumeRatio":0.616759,"shares":2035080810,"dividePrice":2.44,"high":46.91,"amplitude":0.012361,"preClose":46.92,"low":46.33,"week52Low":39.35,"pbRate":"5.45","psRate":"1.99","week52High":63.33,"institutionHeld":0.7058,"latestPrice":46.5333,"committee":-0.676349,"eps":2.670473,"divideRate":0.052436,"volume":5073967,"delay":0,"ttmEps":2.670473,"open":46.87,"prevYearClose":56.56,"prevWeekClose":46.92,"prevMonthClose":46.29,"prevQuarterClose":46.29,"fiveDayClose":46.35,"twentyDayClose":47.84,"sixtyDayClose":53.07,"earningDate":1753891200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538491415","title":"ACADIA Pharmaceuticals Appoints Allyson McMillan-Youngblood as Senior VP, Rare Disease Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2538491415","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538491415?lang=en_us&edition=fundamental","pubTime":"2025-05-28 04:05","pubTimestamp":1748376335,"startTime":"0","endTime":"0","summary":"ACADIA Pharmaceuticals Inc. has appointed Allyson McMillan-Youngblood as Senior Vice President of its Rare Disease Franchise. With over 20 years in the pharmaceutical industry, McMillan-Youngblood will focus on maximizing the potential of DAYBUE and preparing for future product launches as ACADIA expands its rare disease portfolio. She joins from Bristol Myers Squibb, where she served as Senior Vice President and Business Unit Head, U.S. Oncology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire  on May 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nNDL1ScJW1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","LU0061475181.USD","BK4532","IE00BSNM7G36.USD","LU2242646821.SGD","BMY","LU1093756168.USD","LU2360032135.SGD","LU1670711123.USD","IE00BFXG1179.USD","BK4559","LU1093756325.SGD","BK4581","BK4585","LU2065171311.SGD","LU0225771236.USD","LU0306807586.USD","LU1989771016.USD","BK4588","LU1585245621.USD","LU2133065610.SGD","LU1868837136.USD","LU0456855351.SGD","IE00BJT1NW94.SGD","BK4534","LU1291159041.SGD","ACAD","LU1571399168.USD","LU0114720955.EUR","LU0096364046.USD","LU2125154778.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU1868836914.USD","LU0882574055.USD","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU1670710588.SGD","LU1032466523.USD","BK4139","IE0002141913.USD","LU1670711040.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU0868494617.USD","LU1670710661.SGD","IE0009355771.USD","LU0267386448.USD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2538496659","title":"BRIEF-Bristol-Myers Squibb Canada Says New Subcutaneous Formulation Of Opdivo Approved In Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2538496659","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538496659?lang=en_us&edition=fundamental","pubTime":"2025-05-28 01:42","pubTimestamp":1748367770,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol-Myers Squibb Canada Says New Subcutaneous Formulation Of Opdivo Approved In CanadaMay 27 (Reuters) - Bristol-Myers Squibb Canada:BRISTOL-MYERS SQUIBB CANADA: NEW SUBCUTANEOUS FORMULATION","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RZ1HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306806265.USD","LU1868837300.USD","BK4559","IE00BFXG1179.USD","LU1670710588.SGD","LU2242646821.SGD","LU1093756325.SGD","LU1989771016.USD","BK4007","LU1868836757.USD","BK4588","IE0002141913.USD","BMY","LU0225284248.USD","LU1032466523.USD","LU0267386448.USD","LU1291159041.SGD","IE00BJJMRZ35.SGD","LU0096364046.USD","BK4581","LU2125154935.USD","LU2125154778.USD","LU0321505868.SGD","LU1585245621.USD","LU0061475181.USD","LU0225771236.USD","LU1093756168.USD","LU2133065610.SGD","LU0321505439.SGD","BK4534","IE00BJT1NW94.SGD","BK4585","LU0985481810.HKD","LU1718418525.SGD","LU0456855351.SGD","LU1868837136.USD","BK4532","LU0306807586.USD","LU1323610961.USD","LU0237698245.USD","LU1261432733.SGD","LU0882574055.USD","LU1868836591.USD","LU1868836914.USD","LU0868494617.USD","LU1430594728.SGD","LU1074936037.SGD","LU2360032135.SGD","IE00BSNM7G36.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2538678794","title":"Bristol-Myers Squibb Canada: New Subcutaneous Formulation of Opdivo Approved in Canada for Use Across All Authorized Solid Tumour Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2538678794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538678794?lang=en_us&edition=fundamental","pubTime":"2025-05-27 22:16","pubTimestamp":1748355376,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RZ1HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","LU0985481810.HKD","LU1430594728.SGD","LU1868837300.USD","LU1074936037.SGD","IE00BSNM7G36.USD","LU1323610961.USD","IE0002141913.USD","LU0321505868.SGD","LU1670710588.SGD","IE00BJJMRZ35.SGD","IE00BFXG1179.USD","LU2133065610.SGD","LU1093756168.USD","BK4534","IE0009355771.USD","LU1718418525.SGD","LU2125154935.USD","BK4532","LU0114720955.EUR","BK4559","BMY","LU0321505439.SGD","BK4588","LU0061475181.USD","LU1571399168.USD","LU1261432733.SGD","LU0225284248.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","IE00BJT1NW94.SGD","LU1868837136.USD","LU0306807586.USD","LU0096364046.USD","LU0225771236.USD","LU1868836591.USD","BK4585","LU0267386448.USD","LU1989771016.USD","BK4581","LU1032466523.USD","LU1868836914.USD","LU2360032135.SGD","LU0237698245.USD","LU0306806265.USD","LU1670710661.SGD","LU0882574055.USD","LU1585245621.USD","LU1670711040.USD"],"gpt_icon":0},{"id":"2537631731","title":"Prothena Corporation plc Publishes Presentation on Advancements in Life-Saving Therapies for Protein Dysregulation Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2537631731","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537631731?lang=en_us&edition=fundamental","pubTime":"2025-05-24 08:21","pubTimestamp":1748046069,"startTime":"0","endTime":"0","summary":"Prothena Corporation plc has released a presentation detailing its ongoing efforts in developing life-saving therapies for diseases related to protein dysregulation, such as Alzheimer's disease, Parkinson's disease, and transthyretin amyloidosis. The presentation highlights the company's focus on therapeutics engineered to eliminate pathogenic proteins while preserving normal biology, utilizing a biology-directed engine for disease-driven antibody engineering. It outlines multiple clinical programs, including three partnered Phase 2 programs and one wholly-owned Phase 1 program. Prothena has established strong collaborations with partners like Bristol Myers Squibb, Novo Nordisk, and Roche. The presentation also emphasizes the global impact of neurodegenerative diseases and the economic burden they pose. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250524:nNDLb901jq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE0002141913.USD","BK4139","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU2125154935.USD","LU0985481810.HKD","BK4534","LU2360032135.SGD","BK4559","LU0061475181.USD","LU0882574055.USD","BK4585","LU0114720955.EUR","IE00B2B36J28.USD","LU0321505868.SGD","LU1718418525.SGD","BMY","LU0267386448.USD","LU0868494617.USD","LU1670711123.USD","LU1093756168.USD","BK4007","LU1670710588.SGD","LU1670710661.SGD","LU0306806265.USD","LU1261432733.SGD","LU1989771016.USD","LU2242652126.USD","LU2125154778.USD","LU1585245621.USD","BK4581","IE00BFXG1179.USD","LU2242646821.SGD","LU0321505439.SGD","LU1868836914.USD","LU0237698245.USD","LU1868836591.USD","LU0306807586.USD","LU1032466523.USD","LU1868836757.USD","PRTA","LU1571399168.USD","LU0096364046.USD","BK4588","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU0456855351.SGD","LU0225771236.USD"],"gpt_icon":0},{"id":"2537901992","title":"Bloomsbury Publishing (BMY) Gets a Buy from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2537901992","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537901992?lang=en_us&edition=fundamental","pubTime":"2025-05-23 13:45","pubTimestamp":1747979107,"startTime":"0","endTime":"0","summary":"In a report released yesterday, William Larwood from Berenberg Bank initiated coverage with a Buy rating on Bloomsbury Publishing (BMY – Research R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bloomsbury-publishing-bmy-gets-a-buy-from-berenberg-bank?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bloomsbury-publishing-bmy-gets-a-buy-from-berenberg-bank?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0061475181.USD","IE0009355771.USD","BK4532","IE00BSNM7G36.USD","LU1074936037.SGD","LU1868837300.USD","LU2242646821.SGD","BMY","LU1093756168.USD","LU2360032135.SGD","LU1670711123.USD","IE00BFXG1179.USD","BK4559","LU1868836591.USD","LU1093756325.SGD","BK4581","BK4585","LU0225771236.USD","LU0306807586.USD","LU1989771016.USD","BK4588","LU1585245621.USD","LU2133065610.SGD","LU1868837136.USD","LU0456855351.SGD","IE00BJT1NW94.SGD","BK4007","LU1291159041.SGD","LU1571399168.USD","LU0114720955.EUR","LU2125154778.USD","IE00B2B36J28.USD","LU1868836914.USD","LU1868836757.USD","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU0985481810.HKD","LU1032466523.USD","IE0002141913.USD","LU1670710588.SGD","LU1670711040.USD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU0868494617.USD","LU0306806265.USD","LU1323610961.USD","LU1670710661.SGD","LU0225284248.USD","LU0267386448.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"2537927315","title":"Serina Therapeutics Announces Board Changes: Welcomes Dr. Stephen Brannan, Bids Farewell to Remy Gross","url":"https://stock-news.laohu8.com/highlight/detail?id=2537927315","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537927315?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:41","pubTimestamp":1747946468,"startTime":"0","endTime":"0","summary":"Serina Therapeutics Inc. has appointed Stephen Brannan, M.D., to its Board of Directors. Dr. Brannan, a seasoned expert in neuroscience drug development, has previously served as Chief Medical Officer at Karuna Therapeutics. Concurrently, Remy Gross has departed from the Board of Directors and will continue to support the company in a consulting role.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Serina Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL26hqfz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836914.USD","LU0114720955.EUR","LU1430594728.SGD","LU1868837136.USD","LU0321505868.SGD","LU1868837300.USD","LU1032466523.USD","LU2125154778.USD","LU0225771236.USD","LU0306806265.USD","LU1868836591.USD","LU0456855351.SGD","LU1670710588.SGD","BK4534","LU2242652126.USD","BK4585","LU2242646821.SGD","IE00BJJMRZ35.SGD","SER","LU2360032135.SGD","LU0868494617.USD","LU1074936037.SGD","LU1093756325.SGD","LU0061475181.USD","BK4532","BK4139","LU0096364046.USD","LU0225284248.USD","LU0882574055.USD","LU1718418525.SGD","LU1989771016.USD","LU1585245621.USD","LU0321505439.SGD","BK4007","LU2133065610.SGD","LU1093756168.USD","LU1868836757.USD","IE0002141913.USD","BMY","LU1291159041.SGD","LU2125154935.USD","IE00B2B36J28.USD","LU1261432733.SGD","BK4588","LU1670710661.SGD","LU0237698245.USD","LU1323610961.USD","LU0267386448.USD","IE00BFTCPJ56.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2537513509","title":"Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2537513509","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537513509?lang=en_us&edition=fundamental","pubTime":"2025-05-22 04:40","pubTimestamp":1747860000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  slid 1.82% to $47.00 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 1.61% to 5,844.61 and Dow Jones Industrial Average  falling 1.91% to 41,860.44.The stock's fall snapped a four-day winning streak.Bristol Myers Squibb Co. closed 25.79% below its 52-week high of $63.33, which the company achieved on March 11th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.31% to $153.18, Pfizer Inc.  fell 2.04% to $23.04, and Abbott Laboratories  fell 1.59% to $133.05.Trading volume  remained 3.3 million below its 50-day average volume of 15.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 21, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published ind","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2537984016","title":"Bristol Myers Squibb to Participate in Bernstein 41st Annual Strategic Decisions Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2537984016","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537984016?lang=en_us&edition=fundamental","pubTime":"2025-05-21 18:59","pubTimestamp":1747825150,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb will participate in the Bernstein 41st Annual Strategic Decisions Conference on Wednesday, May 28, 2025. The company is set to engage in a fireside chat beginning at 3:30 p.m. ET, which will be accessible to investors and the general public via their investor relations website. An archived version of the session will also be available after its conclusion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief via Business Wire  on May 21, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL5MccNV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","BK4007","BK4534","LU0225771236.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","IE00BFXG1179.USD","LU0306806265.USD","LU1032466523.USD","IE0002141913.USD","BK4559","LU0868494617.USD","LU1571399168.USD","LU1074936037.SGD","LU1093756325.SGD","LU0096364046.USD","BK4532","LU1670711123.USD","LU1670710588.SGD","LU1718418525.SGD","BMY","LU1868837136.USD","LU0061475181.USD","BK4588","IE00BJT1NW94.SGD","LU0985481810.HKD","LU0237698245.USD","LU1323610961.USD","LU0267386448.USD","LU1868836914.USD","LU1670710661.SGD","LU2242646821.SGD","BK4581","LU1868837300.USD","LU0456855351.SGD","LU0321505439.SGD","LU2133065610.SGD","IE0009355771.USD","LU1585245621.USD","LU1868836757.USD","LU1291159041.SGD","LU1670711040.USD","LU1093756168.USD","LU0225284248.USD","LU0306807586.USD","LU1868836591.USD","LU0321505868.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2536610016","title":"He called the S&P 500 bottom. Now this stock trader can't rule out a 'flash crash.'","url":"https://stock-news.laohu8.com/highlight/detail?id=2536610016","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536610016?lang=en_us&edition=fundamental","pubTime":"2025-05-20 21:08","pubTimestamp":1747746480,"startTime":"0","endTime":"0","summary":"Theo Trade's Jeff Bierman: 'You have to be very careful how you approach this market.'. 'If you get a 5% to 6% return from the S&P 500 over the next three to four years, you've done very well.'. What's in the box, according to Bierman, is a \"mercurial president; on any given day, there can be a tweet, a social media post or a television appearance where one word from him drives order flow. Each morning, I wake up and wonder what he's going to do to torch my portfolio or lift it up.\". Bierman: We did take out 5,600 and went down to 4,800. Now, we have circled back to 5,800. Let me put it in perspective: The all-time high on the S&P 500 is 6,147 on February 19. Then we","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".SPX","UPRO","LU1868837300.USD","LU2381873111.SGD","SDS","ESmain","MA","BAX","LU1642822529.SGD","BRK.A","SSO","TGT","LU2326559502.SGD","IVV","SH","VOO","IE0034235295.USD","OEX","MESmain","ON","LU1633808545.USD","DELL","IE00B4R5TH58.HKD","LU0965509010.AUD","LU0868494708.USD","LU2506951958.HKD","LU2242652126.USD","SPXU","IE00BKVL7J92.USD","SPY","BJ","LU1670628061.USD","BRK.B","OEF","STX","COST","LU1585245621.USD","LU1989772840.SGD","LU2360107325.USD","MRK","SG9999014880.SGD","WMT","V","LU0321505868.SGD","LU2357305700.SGD","LU1868836591.USD","LU2506951875.HKD","WDC","LU0056508442.USD","BMY"],"gpt_icon":0},{"id":"2536306836","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2536306836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536306836?lang=en_us&edition=fundamental","pubTime":"2025-05-20 04:40","pubTimestamp":1747687200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  advanced 1.01% to $47.22 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.09% to 5,963.60 and the Dow Jones Industrial Average  rising 0.32% to 42,792.07.This was the stock's third consecutive day of gains.Bristol Myers Squibb Co. closed 25.44% short of its 52-week high of $63.33, which the company reached on March 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.77% to $152.49, Pfizer Inc.  rose 0.74% to $23.00, and Abbott Laboratories  rose 0.56% to $135.55.Trading volume  remained 5.7 million below its 50-day average volume of 15.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2536681478","title":"Prime Medicine Announces Promising Initial Clinical Data for PM359 in Chronic Granulomatous Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2536681478","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536681478?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:30","pubTimestamp":1747657815,"startTime":"0","endTime":"0","summary":"Prime Medicine Inc. has announced encouraging preliminary results from the first patient dosed in a Phase 1/2 clinical trial of PM359, an investigational Prime Editor for Chronic Granulomatous Disease . The initial data revealed that a single dose of PM359 led to a significant improvement in DHR positivity, with levels reaching 58% by Day 15 and 66% by Day 30, surpassing those believed to be potentially curative. The treatment was well-tolerated with no serious adverse events reported. Prime Medicine plans to explore continued clinical development opportunities for PM359 outside the company. Additionally, the firm will concentrate on advancing its programs targeting genetic liver diseases like Wilson's Disease and Alpha-1 Antitrypsin Deficiency, and its in vivo Cystic Fibrosis program, supported by the Cystic Fibrosis Foundation. Prime Medicine also aims to develop Prime Edited CAR-T products in collaboration with Bristol Myers Squibb.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL5kTDKM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0882574055.USD","IE00BSNM7G36.USD","BK4112","LU0061475181.USD","LU2210149790.SGD","BK4007","IE00BJT1NW94.SGD","IE00BKPKM429.USD","NDAQ","BK4534","LU2125154935.USD","PRME","LU0096364046.USD","BMY","LU0114720955.EUR","LU1670710661.SGD","IE00BFXG1179.USD","LU1718418525.SGD","IE0002141913.USD","IE00B3QW5Z07.USD","IE0009355771.USD","LU2125154778.USD","IE00B64PRP62.GBP","BK4139","LU2210150020.SGD","LU0306806265.USD","LU0225771236.USD","IE00BGHQF748.EUR","LU1585245621.USD","LU0237698245.USD","LU2360032135.SGD","LU1032466523.USD","LU1868836757.USD","LU1093756325.SGD","LU1989771016.USD","BK4588","LU0456855351.SGD","BK4585","LU0868494617.USD","LU0321505868.SGD","LU1670711040.USD","LU1093756168.USD","LU1323610961.USD","LU1074936037.SGD","LU2242646821.SGD","LU0267386448.USD","LU0985481810.HKD","LU0321505439.SGD","LU1868837136.USD"],"gpt_icon":0},{"id":"2536892536","title":"This stock trader called a bottom for the S&P 500. Here's what he's saying now.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536892536","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536892536?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:05","pubTimestamp":1747656300,"startTime":"0","endTime":"0","summary":"Theo Trade's Jeff Bierman: 'You have to be very careful how you approach this market. I would not rule out a 2009-style flash crash.'. 'If you get a 5% to 6% return from the S&P 500 over the next three to four years, you've done very well.'. What's in the box, according to Bierman, is a \"mercurial president; on any given day, there can be a tweet, a social media post or a television appearance where one word from him drives order flow. Each morning, I wake up and wonder what he's going to do to torch my portfolio or lift it up.\". Bierman: We did take out 5,600 and went down to 4,800. Now, we have circled back to 5,800. Let me put it in perspective: The all-time high on t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPXU","LU1941712264.USD","BRK.A","ESmain","UPRO","LU1868836591.USD","LU1670711123.USD","TGT","SDS","STX","OEF","MA","LU1084165304.USD","V","LU0006061336.USD","LU0690374961.EUR","LU2324357040.USD","IE00BK4W5M84.HKD","BK4504","VOO","LU0124676726.USD","BJ","IVV","LU2360032135.SGD","LU0276348264.USD",".SPX","LU0124384867.USD","LU0957791311.USD","BMY","SG9999015341.SGD","SPY","LU0175139822.USD","SSO","OEX","WDC","MESmain","LU0234572021.USD","LU1548497426.USD","LU0057025933.USD","GB00B4LPDJ14.GBP","SH","LU0081259029.USD","LU0157215616.USD","ON","BAX"],"gpt_icon":1},{"id":"2536525161","title":"European Commission Approves Opdivo Regimen for Treatment of High-Risk Non-Small Cell Lung Cancer, Announce ONO Pharmaceutical and Bristol Myers Squibb","url":"https://stock-news.laohu8.com/highlight/detail?id=2536525161","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536525161?lang=en_us&edition=fundamental","pubTime":"2025-05-19 11:02","pubTimestamp":1747623737,"startTime":"0","endTime":"0","summary":"European Commission Approves Opdivo Regimen for Treatment of High-Risk Non-Small Cell Lung Cancer, Announce ONO Pharmaceutical and Bristol Myers Squibb. ONO Pharmaceutical Co. Ltd., in partnership with Bristol Myers Squibb, has received approval from the European Commission for a new perioperative regimen involving the use of Opdivo  in combination with chemotherapy, followed by adjuvant Opdivo for the treatment of resectable, high-risk non-small cell lung cancer with PD-L1 expression levels of 1% or more. This approval marks a significant advancement in the treatment options available for patients with this type of lung cancer, supporting ONO Pharmaceutical and Bristol Myers Squibb's ongoing efforts to improve cancer care.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDLc2PxnQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1323610961.USD","LU2242652126.USD","BK4532","LU1868836591.USD","LU1868837300.USD","LU2242646821.SGD","LU1868836914.USD","LU1291159041.SGD","LU1074936037.SGD","LU0267386448.USD","LU0985481810.HKD","LU2360032135.SGD","LU0868494617.USD","BMY","LU1868837136.USD","LU0306806265.USD","IE0009355771.USD","LU0061475181.USD","LU1032466523.USD","LU1670710588.SGD","LU1261432733.SGD","LU1670711040.USD","BK4588","IE0002141913.USD","BK4559","LU0114720955.EUR","LU0225771236.USD","IE00B2B36J28.USD","BK4534","LU1868836757.USD","LU1093756168.USD","LU2125154778.USD","LU1670710661.SGD","IE00BFTCPJ56.SGD","BK4581","LU0456855351.SGD","LU1430594728.SGD","LU1718418525.SGD","LU1571399168.USD","IE00BFXG1179.USD","BK4007","LU2133065610.SGD","LU0237698245.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0306807586.USD","LU1093756325.SGD","LU1585245621.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"2536134029","title":"Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as New Head of R&D and Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2536134029","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536134029?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:15","pubTimestamp":1747426558,"startTime":"0","endTime":"0","summary":"Syndax Pharmaceuticals Inc. has appointed Dr. Nicholas Botwood as the new Head of Research and Development and Chief Medical Officer. Dr. Botwood, previously with Bristol Myers Squibb, brings over 25 years of experience in drug development and oncology. He succeeds Dr. Neil Gallagher, who is leaving the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syndax Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL4Dg6Xy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU0237698245.USD","LU0225284248.USD","IE00B2B36J28.USD","IE00BFXG1179.USD","LU0225771236.USD","LU1430594728.SGD","LU1670711123.USD","LU0456855351.SGD","IE0002141913.USD","BK4534","LU1032466523.USD","LU0306807586.USD","LU1291159041.SGD","LU0061475181.USD","BK4581","SNDX","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU2242652126.USD","LU0985481810.HKD","LU1670710661.SGD","LU2242646821.SGD","BK4585","BK4588","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU1093756325.SGD","LU1571399168.USD","LU2125154778.USD","LU0306806265.USD","LU2360032135.SGD","BMY","LU0267386448.USD","LU0096364046.USD","LU1585245621.USD","LU1989771016.USD","LU2125154935.USD","LU1868836591.USD","BK4559","BK4139","BK4007","LU1868836757.USD","LU1323610961.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","IE0009355771.USD","BK4532"],"gpt_icon":0},{"id":"2535939971","title":"Bristol-Myers Squibb Receives European Approval for Opdivo Regimen to Treat Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2535939971","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535939971?lang=en_us&edition=fundamental","pubTime":"2025-05-16 19:51","pubTimestamp":1747396261,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb  said Friday it received European Commission approval for the perioperative regimen of neoadjuvant Opdivo and chemotherapy followed by surgery and adjuvant Opdivo to treat resectable non-small cell lung cancer.The approval covers treatment of cancer at high risk of recurrence in adult patients whose tumors have PD-L1 expression greater than or equal to 1%, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","BK4534","LU0267386448.USD","LU0456855351.SGD","LU1093756168.USD","LU1868836757.USD","LU0882574055.USD","LU1670711123.USD","LU1670710588.SGD","LU1989771016.USD","IE0009355771.USD","IE0002141913.USD","BK4585","LU1032466523.USD","LU1868836591.USD","LU2133065610.SGD","BK4559","LU0306807586.USD","BK4532","LU1261432733.SGD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","BK4588","LU1093756325.SGD","LU0321505868.SGD","LU0237698245.USD","LU1718418525.SGD","BK4581","LU0868494617.USD","LU1323610961.USD","LU1585245621.USD","BMY","LU1571399168.USD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU0225771236.USD","LU0225284248.USD","LU0321505439.SGD","LU0096364046.USD","LU2360032135.SGD","LU1670710661.SGD","LU1074936037.SGD","LU2125154935.USD","LU1430594728.SGD","BK4007","LU2242652126.USD","IE00BFXG1179.USD","LU0114720955.EUR","LU1868837136.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2535396295","title":"BRIEF-Bristol Myers Squibb Receives European Commission Approval For Perioperative Regimen Of Neoadjuvant Opdivo(Nivolumab) And Chemotherapy Followed By Adjuvant Opdivo For Resectable, High-Risk Non-Small Cell Lung Cancer With Pd-L1 Expression ≥1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535396295","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535396295?lang=en_us&edition=fundamental","pubTime":"2025-05-16 19:31","pubTimestamp":1747395109,"startTime":"0","endTime":"0","summary":"BRIEF-Bristol Myers Squibb Receives European Commission Approval For Perioperative Regimen Of Neoadjuvant Opdivo(Nivolumab) And Chemotherapy Followed By Adjuvant Opdivo For Resectable, High-Risk Non-S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nTUA3XWJM0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837136.USD","LU2133065610.SGD","LU0237698245.USD","LU0225284248.USD","LU1868837300.USD","IE00BFXG1179.USD","LU0225771236.USD","LU1430594728.SGD","LU1670711123.USD","LU0456855351.SGD","LU1032466523.USD","BK4534","LU1291159041.SGD","LU0306807586.USD","LU1670710588.SGD","LU0061475181.USD","BK4581","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU2242652126.USD","LU0114720955.EUR","LU0985481810.HKD","LU1670710661.SGD","LU1074936037.SGD","LU2242646821.SGD","BK4588","LU1261432733.SGD","LU1868836914.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU1571399168.USD","LU0306806265.USD","LU2360032135.SGD","BMY","LU0267386448.USD","LU0096364046.USD","LU1585245621.USD","LU1718418525.SGD","LU1989771016.USD","LU2125154935.USD","LU1868836591.USD","BK4007","LU0321505439.SGD","LU0868494617.USD","LU1868836757.USD","LU1323610961.USD","LU0321505868.SGD","IE0009355771.USD","BK4532"],"gpt_icon":0},{"id":"2535039314","title":"Bristol-Myers Squibb Secures European Commission Approval for Opdivo Regimen in Treating High-Risk Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2535039314","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535039314?lang=en_us&edition=fundamental","pubTime":"2025-05-16 18:59","pubTimestamp":1747393177,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Secures European Commission Approval for Opdivo Regimen in Treating High-Risk Non-Small Cell Lung Cancer. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief via Business Wire  on May 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL4RgXkJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU1585245621.USD","LU0868494617.USD","BMY","LU1670711040.USD","LU1868837300.USD","LU0096364046.USD","IE00BFXG1179.USD","LU0061475181.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU2133065610.SGD","LU2125154935.USD","BK4007","LU0321505868.SGD","LU0882574055.USD","LU0225771236.USD","LU1093756168.USD","LU1718418525.SGD","IE0002141913.USD","LU1670710588.SGD","LU0237698245.USD","IE00BFTCPJ56.SGD","LU0985481810.HKD","LU1074936037.SGD","LU0114720955.EUR","LU0306806265.USD","LU1571399168.USD","LU0456855351.SGD","LU1868836591.USD","LU2242652126.USD","LU1323610961.USD","LU2242646821.SGD","LU0267386448.USD","LU1032466523.USD","LU1670710661.SGD","LU1989771016.USD","BK4585","IE00BJT1NW94.SGD","LU1261432733.SGD","LU1868836914.USD","LU2125154778.USD","LU2360032135.SGD","LU1430594728.SGD","IE00B2B36J28.USD","LU0306807586.USD","IE00BSNM7G36.USD","LU1291159041.SGD","LU1670711123.USD","BK4581"],"gpt_icon":0},{"id":"2535145393","title":"Bristol Myers Squibb Receives European Commission Approval for Perioperative Regimen of Neoadjuvant Opdivo® (Nivolumab) and Chemotherapy Followed by Adjuvant Opdivo for Resectable, High-Risk Non-Small Cell Lung Cancer With Pd-L1 Expression ≥1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535145393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535145393?lang=en_us&edition=fundamental","pubTime":"2025-05-16 18:59","pubTimestamp":1747393140,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nTUA3XWJM0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1585245621.USD","LU2360032135.SGD","LU0061475181.USD","LU2242646821.SGD","IE0002141913.USD","LU1670710661.SGD","LU0985481810.HKD","BK4581","LU1291159041.SGD","LU1670711040.USD","IE00BSNM7G36.USD","LU1670710588.SGD","BK4007","LU0306807586.USD","LU0267386448.USD","LU0321505868.SGD","IE00BFXG1179.USD","LU0096364046.USD","LU1670711123.USD","LU1074936037.SGD","IE00B2B36J28.USD","LU0882574055.USD","IE00BJT1NW94.SGD","LU1718418525.SGD","LU1093756325.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU0456855351.SGD","LU1868836914.USD","LU0225771236.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU1430594728.SGD","LU1868836591.USD","LU0306806265.USD","LU2133065610.SGD","LU0114720955.EUR","LU2125154935.USD","LU2242652126.USD","LU1868837300.USD","LU1093756168.USD","LU1032466523.USD","BK4585","LU1261432733.SGD","BMY","LU1323610961.USD","LU0237698245.USD","LU1989771016.USD","LU2125154778.USD","LU0225284248.USD"],"gpt_icon":0},{"id":"2535490844","title":"Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2535490844","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535490844?lang=en_us&edition=fundamental","pubTime":"2025-05-15 20:03","pubTimestamp":1747310632,"startTime":"0","endTime":"0","summary":"Janux Therapeutics Inc., a clinical-stage biopharmaceutical company, announced the appointment of Janeen Doyle as Chief Corporate and Business Development Officer. With over 24 years of experience in corporate strategy and business development across biotech, pharma, and venture ecosystems, Doyle joins Janux from Flagship Pioneering, where she was a Senior Partner and Senior Vice President. Her extensive background includes roles at Bristol Myers Squibb and Celgene, focusing on strategic collaborations and business development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Janux Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 15, 2025, and is solely responsible for the inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL3G8l2v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JANX","LU1571399168.USD","LU2360032135.SGD","LU0237698245.USD","LU1868837300.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1868836757.USD","LU1868836591.USD","LU0306807586.USD","LU0061475181.USD","BK4007","BK4559","LU1585245621.USD","LU1670711123.USD","BK4585","LU0306806265.USD","LU1670710661.SGD","LU1868836914.USD","LU1868837136.USD","LU2133065610.SGD","IE00BSNM7G36.USD","BK4534","IE00BJJMRZ35.SGD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU2125154935.USD","LU0225284248.USD","LU2125154778.USD","BK4139","LU1093756168.USD","LU0985481810.HKD","IE00BFXG1179.USD","LU0267386448.USD","LU1989771016.USD","BK4581","BK4588","LU0114720955.EUR","LU1670711040.USD","LU0456855351.SGD","LU0321505868.SGD","LU0225771236.USD","LU1261432733.SGD","LU0321505439.SGD","LU1323610961.USD","BMY","LU2242646821.SGD","BK4539","LU1032466523.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"2535436000","title":"Bristol Myers Squibb Co. Stock Slides 5.3%, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2535436000","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535436000?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:34","pubTimestamp":1747254840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Bristol Myers Squibb Co. shed 5.3% to $44.12 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.1% to 5,892.58 and the Dow Jones Industrial Average falling 0.2% to 42,051.06.This was the stock's second consecutive day of losses.Bristol Myers Squibb Co. closed 30.3% below its 52-week high of $63.33, which the company reached on March 11th.The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 1.4% to $146.36, Pfizer Inc. fell 3.7% to $22.02, and Abbott Laboratories fell 0.38% to $128.56.Trading volume totaled 21.7 million, compared to the 50-day average of 15.0 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"date":"2025-07-31","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":1.53,"defaultRemindTime":1753948800000,"name":null,"time":"Pre-Market","dateTimestamp":1753934400000,"actualEps":null},{"date":"2025-07-03","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-03","defaultRemindTime":1751549400000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-01","payableDate":"2025-07-03","currency":"USD","dateTimestamp":1751515200000,"payDate":"2025-08-01"},{"market":"US","date":"2025-04-24","symbol":"BMY","fiscalQuarterEnding":"2025/03","expectedEps":1.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"pre","actualEps":1.8},{"date":"2025-04-04","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-04","defaultRemindTime":1743773400000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-04","currency":"USD","dateTimestamp":1743739200000,"payDate":"2025-05-01"},{"market":"US","date":"2025-02-06","symbol":"BMY","fiscalQuarterEnding":"2024/12","expectedEps":1.46,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-30","recordDate":"2015-10-02","paymentDate":"2015-11-02","value":0.37,"currency":"USD"},{"executeDate":"2015-12-30","recordDate":"2016-01-04","paymentDate":"2016-02-01","value":0.38,"currency":"USD"},{"executeDate":"2016-03-30","recordDate":"2016-04-01","paymentDate":"2016-05-02","value":0.38,"currency":"USD"},{"executeDate":"2016-06-29","recordDate":"2016-07-01","paymentDate":"2016-08-01","value":0.38,"currency":"USD"},{"executeDate":"2016-10-05","recordDate":"2016-10-07","paymentDate":"2016-11-01","value":0.38,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1071,"buy":0.1429,"hold":0.6786,"sell":0.0714,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6786,"analysts":28,"updateTime":1745380800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2025-07-03","current":17.620593,"percent":0.656098,"low":-3427.632189,"twenty":-24.206195,"median":12.014526,"eighty":22.817575,"high":143.232531,"avg":-167.74167,"sd":700.96466,"marketCap":95485991605},"quantilePoints":[{"date":"2020-07-10","current":136.212026,"twenty":26.163897,"median":42.354947,"eighty":59.954728,"marketCap":129946272629},{"date":"2020-07-17","current":143.232531,"twenty":26.163897,"median":42.505381,"eighty":60.343483,"marketCap":136643834304},{"date":"2020-07-24","current":137.208179,"twenty":26.163897,"median":42.754058,"eighty":60.719618,"marketCap":130896602326},{"date":"2020-07-31","current":139.12933,"twenty":26.163897,"median":43.2132,"eighty":60.965815,"marketCap":132729381028},{"date":"2020-08-07","current":-244.289683,"twenty":26.104809,"median":43.30835,"eighty":63.241479,"marketCap":137535091427},{"date":"2020-08-14","current":-252.857036,"twenty":25.671207,"median":43.30835,"eighty":63.241479,"marketCap":142358511546},{"date":"2020-08-21","current":-248.973703,"twenty":24.738199,"median":43.30835,"eighty":63.241479,"marketCap":140172194950},{"date":"2020-08-28","current":-249.694322,"twenty":24.53695,"median":43.30835,"eighty":63.241479,"marketCap":140577903184},{"date":"2020-09-04","current":-240.006006,"twenty":24.217273,"median":43.30835,"eighty":63.241479,"marketCap":135123381368},{"date":"2020-09-11","current":-236.162707,"twenty":23.958745,"median":43.30835,"eighty":63.241479,"marketCap":132959604118},{"date":"2020-09-18","current":-237.283669,"twenty":23.923139,"median":43.30835,"eighty":63.241479,"marketCap":133590705816},{"date":"2020-09-25","current":-238.164425,"twenty":23.703169,"median":43.30835,"eighty":63.241479,"marketCap":134086571436},{"date":"2020-10-02","current":-235.081779,"twenty":23.363915,"median":43.30835,"eighty":63.241479,"marketCap":132351041767},{"date":"2020-10-09","current":-247.492432,"twenty":17.593463,"median":43.30835,"eighty":63.241479,"marketCap":139338239135},{"date":"2020-10-16","current":-245.170439,"twenty":17.05085,"median":43.30835,"eighty":63.241479,"marketCap":138030957047},{"date":"2020-10-23","current":-240.726625,"twenty":16.915253,"median":43.30835,"eighty":63.241479,"marketCap":135529089602},{"date":"2020-10-30","current":-234.000852,"twenty":16.878905,"median":43.30835,"eighty":63.241479,"marketCap":131742479415},{"date":"2020-11-06","current":-3276.639701,"twenty":16.797113,"median":43.30835,"eighty":63.241479,"marketCap":144172146848},{"date":"2020-11-13","current":-3267.395263,"twenty":16.644024,"median":43.30835,"eighty":63.241479,"marketCap":143765391575},{"date":"2020-11-20","current":-3164.165705,"twenty":16.603263,"median":43.30835,"eighty":63.241479,"marketCap":139223291023},{"date":"2020-11-27","current":-3238.121209,"twenty":16.551974,"median":43.30835,"eighty":63.241479,"marketCap":142477333209},{"date":"2020-12-04","current":-3200.116297,"twenty":16.449584,"median":43.30835,"eighty":63.241479,"marketCap":140805117086},{"date":"2020-12-11","current":-3118.457095,"twenty":16.271128,"median":43.30835,"eighty":63.241479,"marketCap":137212112172},{"date":"2020-12-18","current":-3241.716269,"twenty":16.177691,"median":43.24944,"eighty":63.241479,"marketCap":142635515816},{"date":"2020-12-24","current":-3140.54103,"twenty":15.969441,"median":43.24944,"eighty":63.241479,"marketCap":138183805325},{"date":"2020-12-31","current":-3185.73606,"twenty":15.745139,"median":43.24944,"eighty":63.241479,"marketCap":140172386661},{"date":"2021-01-08","current":-3209.360735,"twenty":15.520794,"median":43.24944,"eighty":63.241479,"marketCap":141211872359},{"date":"2021-01-15","current":-3417.360591,"twenty":15.454453,"median":43.24944,"eighty":63.241479,"marketCap":150363866007},{"date":"2021-01-22","current":-3315.671773,"twenty":15.292279,"median":43.24944,"eighty":63.241479,"marketCap":145889558002},{"date":"2021-01-29","current":-3154.921267,"twenty":15.193414,"median":43.24944,"eighty":63.241479,"marketCap":138816535750},{"date":"2021-02-05","current":-15.270556,"twenty":15.111639,"median":43.24944,"eighty":63.241479,"marketCap":137664062476},{"date":"2021-02-12","current":-14.909163,"twenty":15.037512,"median":43.24944,"eighty":63.241479,"marketCap":134406104428},{"date":"2021-02-19","current":-15.060765,"twenty":14.994264,"median":43.24944,"eighty":63.241479,"marketCap":135772794271},{"date":"2021-02-26","current":-15.24219,"twenty":14.895142,"median":43.24944,"eighty":63.241479,"marketCap":137408341133},{"date":"2021-03-05","current":-15.018515,"twenty":14.827729,"median":43.252713,"eighty":64.853776,"marketCap":135391913495},{"date":"2021-03-12","current":-15.070706,"twenty":14.750073,"median":43.252713,"eighty":64.853776,"marketCap":135862413277},{"date":"2021-03-19","current":-15.582672,"twenty":14.671279,"median":43.252713,"eighty":64.853776,"marketCap":140477792093},{"date":"2021-03-26","current":-15.84441,"twenty":14.611498,"median":43.24944,"eighty":63.241479,"marketCap":142837352227},{"date":"2021-04-01","current":-15.59413,"twenty":14.591649,"median":43.24944,"eighty":63.241479,"marketCap":140581085012},{"date":"2021-04-09","current":-15.514834,"twenty":14.520487,"median":43.252713,"eighty":64.853776,"marketCap":139866228072},{"date":"2021-04-16","current":-16.221067,"twenty":14.424522,"median":43.252713,"eighty":64.853776,"marketCap":146232922690},{"date":"2021-04-23","current":-16.357358,"twenty":14.234366,"median":43.246167,"eighty":64.853776,"marketCap":147461583055},{"date":"2021-04-30","current":-22.411016,"twenty":14.031315,"median":41.99272,"eighty":64.853776,"marketCap":139374107187},{"date":"2021-05-07","current":-23.136268,"twenty":13.765653,"median":40.725784,"eighty":64.853776,"marketCap":143884451572},{"date":"2021-05-14","current":-23.294244,"twenty":13.598846,"median":40.216454,"eighty":64.853776,"marketCap":144866902824},{"date":"2021-05-21","current":-24.073352,"twenty":13.387812,"median":39.861196,"eighty":64.853776,"marketCap":149712173772},{"date":"2021-05-28","current":-23.595834,"twenty":13.305536,"median":39.584885,"eighty":64.853776,"marketCap":146742491578},{"date":"2021-06-04","current":-23.315786,"twenty":13.183703,"median":39.110931,"eighty":64.853776,"marketCap":145000873449},{"date":"2021-06-11","current":-24.177472,"twenty":13.076111,"median":38.321748,"eighty":64.853776,"marketCap":150359698461},{"date":"2021-06-18","current":-23.865111,"twenty":12.918943,"median":37.341182,"eighty":64.853776,"marketCap":148417124394},{"date":"2021-06-25","current":-23.962051,"twenty":12.713253,"median":37.032625,"eighty":64.853776,"marketCap":149019992208},{"date":"2021-07-02","current":-24.037448,"twenty":12.656819,"median":36.735495,"eighty":64.853776,"marketCap":149488889397},{"date":"2021-07-09","current":-24.112846,"twenty":12.542371,"median":36.569788,"eighty":64.853776,"marketCap":149957786585},{"date":"2021-07-16","current":-24.163111,"twenty":12.276028,"median":36.398367,"eighty":64.853776,"marketCap":150270384711},{"date":"2021-07-23","current":-24.536508,"twenty":12.058207,"median":36.20409,"eighty":64.853776,"marketCap":152592542216},{"date":"2021-07-30","current":-29.693807,"twenty":11.96591,"median":36.009813,"eighty":61.057,"marketCap":150814846842},{"date":"2021-08-06","current":-29.803185,"twenty":-14.753585,"median":35.906961,"eighty":60.876911,"marketCap":151370375230},{"date":"2021-08-13","current":-29.536304,"twenty":-14.987324,"median":35.781252,"eighty":60.876911,"marketCap":150014885963},{"date":"2021-08-20","current":-30.275696,"twenty":-15.059273,"median":34.627419,"eighty":60.876911,"marketCap":153770257867},{"date":"2021-08-27","current":-29.138169,"twenty":-15.115938,"median":34.17561,"eighty":60.876911,"marketCap":147992762629},{"date":"2021-09-03","current":-28.705034,"twenty":-15.248154,"median":33.35279,"eighty":60.876911,"marketCap":145792870212},{"date":"2021-09-10","current":-27.62001,"twenty":-15.348311,"median":32.979745,"eighty":60.876911,"marketCap":140282028600},{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-25","current":18.285308,"twenty":-24.204041,"median":12.026806,"eighty":23.356243,"marketCap":99088084638},{"date":"2025-05-02","current":18.63081,"twenty":-24.204041,"median":12.026806,"eighty":23.317376,"marketCap":100960358984},{"date":"2025-05-09","current":17.605571,"twenty":-24.204041,"median":12.026806,"eighty":23.272318,"marketCap":95404588372},{"date":"2025-05-16","current":17.203737,"twenty":-24.204041,"median":12.026806,"eighty":23.222393,"marketCap":93227051906},{"date":"2025-05-23","current":17.661903,"twenty":-24.204041,"median":12.026806,"eighty":23.160274,"marketCap":95709850494},{"date":"2025-05-30","current":17.96985,"twenty":-24.204041,"median":12.026806,"eighty":23.102683,"marketCap":97378616758},{"date":"2025-06-06","current":17.966094,"twenty":-24.204041,"median":12.026806,"eighty":23.03988,"marketCap":97358265950},{"date":"2025-06-13","current":19.036399,"twenty":-24.204041,"median":12.026806,"eighty":23.001392,"marketCap":103158246258},{"date":"2025-06-20","current":17.590549,"twenty":-24.206195,"median":12.014526,"eighty":22.956332,"marketCap":95323185140},{"date":"2025-06-27","current":17.519195,"twenty":-24.206195,"median":12.014526,"eighty":22.892874,"marketCap":94936519786},{"date":"2025-07-03","current":17.620593,"twenty":-24.206195,"median":12.014526,"eighty":22.817575,"marketCap":95485991605}],"updateTime":1751888883902}}}